Clinical Edge Journal Scan

Patients With Chronic Kidney Disease Experiences Modestly Lower Risk for Migraine


 

Key clinical point: Patients with chronic kidney disease (CKD), particularly older adults and women, had a modestly reduced risk of developing migraine over a 16-year follow-up period.

Major finding: During the 16-year follow-up, patients with vs without CKD had an 11% lower risk for migraine (adjusted hazard ratio [aHR] 0.89; P = .006), with the risk being prominently lower among older adults (age ≥ 70 years; aHR 0.69; P < .001) and women (aHR 0.84; P = .006).

Study details: This nationwide, 16-year longitudinal follow-up study included 15,443 participants with CKD, of whom 349 (2.26%) had migraine, and 61,772 participants without CKD, of whom 1901 (3.08%) had migraine.

Disclosures: This study was supported by Bracco Imaging Korea and the National Research Foundation of Korea. The authors declared no conflicts of interest.

Source: Kwon MJ, Kim J-K, Kim M-J, et al. Associations between chronic kidney disease and migraine incidence: Findings from a Korean longitudinal big data study. J Pers Med. 2024;14(4):356 (Mar 28). doi: 10.3390/jpm14040356 Source

Recommended Reading

Risk Factors for Headache in Youth Identified
Migraine ICYMI
Commentary: Migraine and Cardiovascular Risk, April 2024
Migraine ICYMI
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
Migraine ICYMI
First Long-Term Data on Atogepant for Migraine Prevention
Migraine ICYMI
IV Ketamine Promising for Severe Refractory Headache in Children
Migraine ICYMI
Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief
Migraine ICYMI
Lidocaine Nerve Block Effective for Severe, Refractory Migraine in Children
Migraine ICYMI
High-Dose Eicosapentaenoic Acid as a Promising Prophylactic Treatment for Episodic Migraine
Migraine ICYMI
Early Erenumab Outperforms Non-specific Oral Treatments in Migraine Patients With Prior Treatment Failures
Migraine ICYMI
Positive Impact of Anti-CGRP Monoclonal Antibodies on Sleep Quality in Migraine
Migraine ICYMI